Enroll Now
 $79

Target Audience

General health care professionals, physicians, oncologists, neurologists specializing in epilepsy, pediatric neurologists and physician assistants.

Program Overview

Comprehensive review of current FDA approved cannabinoids and future cannabinoid medications currently being researched. Includes an overview of the Endocannabinoid System (ECS), including CB1 and CB2 receptors, to give the learner basic knowledge about the ECS and how cannabinoids interact with this system to treat certain conditions.

Learning Outcomes

To have the knowledge to prescribe cannabinoid medications based on information about the intended use of all available FDA approved cannabinoid medications.

$79
Enroll Now
FDABadge

Educational Objectives

After completing this activity, the participant should be better able to:

  • Identify all current FDA approved and pharmaceutical-grade cannabinoid medications.
  • Summarize the formulation of plant extract cannabinoid medications.
    List the differences between pharmaceutical grade and non-FDA approved cannabinoid medications.
  • Describe receptor activity differences between synthetic and naturally occurring cannabinoids.
  • Discuss with patients the risks of self-medicating with non-FDA approved cannabis products.

Course Materials

  • 1 AMA PRA Category 1 Credit™
  • Instant access to all course materials
  • Printable and downloadable infographics
  • All research materials used for the online course
  • Lifetime, unlimited access
  • 24/7 access
  • No time limits
  • Start anytime
  • Work on your own time and at your own pace
  • Affordably priced

Cited Experts

Dr. Gregory Smith

Greg-Smith-Photo-400x400

Dr. Gregory Smith has been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Harvard University. He first trained on the use of medical cannabis in 2000 in California. He has written extensively on the subject, including his popular textbook, “Medical Cannabis: Basic Science and Clinical Applications” published in 2016, and more recently “Cannabidiol, CBD: What you need to know.” And most recently in 2019, “THCV: Appetite Killer.”

Dr. Kevin Smith

Dr-Kevin-Smith-400x400

Dr. Kevin Smith has also been in primary care practice for over 30 years.  He is board certified in Preventive Medicine and obtained his MPH from Yale University.  He trained on the use of medical Cannabis several years ago and has been very active in educating physicians and other medical professionals.